RegeneRx, headquartered in Bethesda, Maryland, is a publicly-traded biopharmaceutical company focused on the discovery and development of novel molecules to accelerate tissue and organ repair. The Company is currently sponsoring five clinical trials for dermal wound healing, ophthalmic wound healing, and cardiovascular protection and regeneration after heart attack.

Contact Information

3 Bethesda Metro Center
Suite 630
Bethesda, MD 20814

tel: 301-280-1992
fax: 301-280-1996


Investor Relations



Exchange: AMEX
Industry: Drug Manufacturers - Other
Market Cap: $80.9M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.